Charlotte’s Web Maintains Strong Gross Profit Margins Amid Net Revenue Decline

May 12, 2023 · Green Market Report

There was a 57.7% improvement in the adjusted EBITDA loss over the year.

Hemp-based CBD giant Charlotte’s Web Holdings, Inc. (TSX: CWEB) (OTCQX: CWBHF) reported its first-quarter financial results on Thursday ending March 31, 2023. Despite a 12.1% year-over-year fall in net revenue, the company managed to reduce operating expenses by 14%, ending with a solid $61 million cash balance.

The financial review for the quarter painted a nuanced picture. While consolidated net revenue was $17 million, down 12.1% from $19.4 million since the same period last year, gross profit remained strong at $9.9 million or 58.3% of revenue.

Total selling, general, and administrative expenses were successfully reduced by 14.0% to $17.5 million, down from $20.4 million in Q1 2022. The company attributed the reduction as a reflection of actions taken in 2022 to improve operating efficiencies and align personnel and marketing expenses with current revenues.

Although the company reported a net loss of $2.9 million for the first quarter, there was a significant improvement in the adjusted EBITDA loss, which was $3.3 million, a 57.7% improvement compared to the $5.3 million loss in the first quarter last year.

Jessica Saxton, CFO of Charlotte’s Web, cited these cost controls as a successful strategy to counterbalance the softness in the CBD category due to the unregulated environment.

“We continue to maintain healthy gross profit margins and have improved our operating margins, despite a net revenue decline,” Saxton said. The financial maneuvering has enabled the company to support growth plans, notably the launch of ReCreate, a new NSF Certified for Sport lifestyle brand.

On the regulatory front, CEO Jacques Tortoroli expressed optimism. The company is actively supporting federal and state legislative initiatives, including the reintroduction of bill H.R. 1629, aimed at regulating hemp CBD as dietary supplements.

Tortoroli also noted the formation of DeFloria LLC, a collaboration with AJNA BioSciences PBC and British American Tobacco PLC. This new venture is targeting a botanical investigative new drug through the FDA drug development pathway, specifically for a neurological condition.

“We anticipate further progress throughout this year,” said Tortoroli.

Charlotte’s Web in April launched a new lifestyle brand, “ReCreate,” aimed at Millennials and GenZers. The brand’s first offering is “ReCreate Daily Edge,” a broad-spectrum CBD oil tincture developed for sports and cultural lifestyle.

According to the company, the product is meant to aid recovery from intense workouts, promotes calmness under pressure, and supports healthy sleep cycles and focus. The ReCreate brand will also bear the iconic MLB logo and tap into MLB’s base of approximately 180 million fans.

Additionally, the company, in collaboration with AJNA BioSciences PBC and British American Tobacco PLC, has formed DeFloria LLC. This entity is set to pursue a botanical investigative new drug from Charlotte’s Web’s proprietary hemp genetics, aiming at a neurological condition. The first set of phase I clinical trials is slated for the summer of 2023.

The company’s cash and working capital were $60.8 million and $78.5 million, respectively. (Full Story)

In categories:Business CBD Hemp
Next Post

Jushi Sees Sales Slip In First Quarter

Missouri legalization impacted Illinois sales. Jushi Holdings Inc. (CSE: JUSH) (OTCQX: JUSHF) announced its financial results for the first quarter ending March 31, 2023. Total revenue increased 12.9% to $69.9 million over last year’s $61.9 million, but fell sequentially by 9% from $76.8 million.…
Previous Post

How Automation Can Future-Proof Manufacturing

In 2014, Colorado made history as the first state in the country to open recreational dispensaries for legal cannabis sales. No one really knew what to expect, but one thing was clear right away: The infant industry was growing fast.…
Random Post

Opinion: What Main Street operators need to know about rescheduling or descheduling marijuana

Last fall, President Joe Biden called on the leaders of the U.S. departments of Justice and Health and Human Services to “review expeditiously” how marijuana is scheduled. The move opened the door to renewed speculation about how descheduling – or rescheduling – marijuana would…
Random Post

Historic Denver Hotel Launches Equity Crowdfunding Campaign To Fund Cannabis Consumption Lounge

Colorado has been a destination for cannabis tourists since the first sale of recreational marijuana in 2014. But at the time, state laws prohibited consuming cannabis in public places, so those tourists technically didn’t have a place to enjoy their…
Random Post

As Canadian medical cannabis slump continues, survey says cost an issue

The high cost of medical cannabis poses major obstacles for Canadian patients, even as recreational marijuana prices remain low, a new survey of thousands of Canadians suggests. The finding comes as a slump in consumer spending on regulated medical cannabis in Canada continues,…
Random Post

Hawaii Senators Approve Bill To Create Psychedelics Advisory Council To Prepare For Federal Legalization

A Hawaii Senate committee approved a House-passed bill on Wednesday that would create an advisory council to look into possible regulations to provide access to federal “breakthrough therapies” like psilocybin and MDMA. The psychedelics legislation from Rep. Adrian Tam (D) advanced, with…